Skip to content

Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice

Therapept

Laboratory record

SteriGenix Analytical

Publishes methods against named USP chapters with instrumentation identified model by model — Agilent 1260 Infinity II with diode array detection for reversed-phase HPLC, Waters Xevo TQ-S with Acquity UPLC for LC-MS identity, Shimadzu GCMS-QP2020 NX for residual solvents, and Charles River Endosafe for kinetic chromogenic LAL.

Jacksonville, Florida, United States

Published capabilities

Recorded from the laboratory’s own live pages. “Not stated” means the laboratory has not published a position — it is not a statement that the service is unavailable.

Peptide-specific testing
Yes
HPLC
Yes
LC-MS
Yes
Mass spectrometry
Yes
Identity
Yes
Purity
Yes
Amino acid analysis
Not stated
Endotoxin
Yes
Sterility
Not stated

Accreditation and working terms

Accreditation
No accreditation claim. Methods are described as adapted from USP, EP and ICH guidelines, and instruments as qualified per IQ/OQ protocols — method references and instrument qualification are not accreditation.Not yet reviewed
Turnaround time
Standard 5 business days from receipt; 3-day rush at a stated 50% surcharge.
Sample requirements
5–10 mg of dry powder for HPLC plus LC-MS; 25 mg recommended for full panels including LAL and Karl Fischer.
Report policy
Batch ID publicly verifiable via a verification page; raw data retained for a stated minimum of three years.

Sources

  1. SteriGenix Analytical — peptide testing and methodsMethods, instrumentation, turnaround, sample requirements and the intake-paused banner read from the live site on 3 September 2026.

Last reviewed 3 September 2026 · Report an inaccuracy in this record